Page last updated: 2024-09-03

3,7,12-trihydroxycholestan-26-oic acid and pipecolic acid

3,7,12-trihydroxycholestan-26-oic acid has been researched along with pipecolic acid in 1 studies

*pipecolic acid: RN given refers to cpd without isomeric designation [MeSH]

*pipecolic acid: RN given refers to cpd without isomeric designation [MeSH]

Compound Research Comparison

Studies
(3,7,12-trihydroxycholestan-26-oic acid)
Trials
(3,7,12-trihydroxycholestan-26-oic acid)
Recent Studies (post-2010)
(3,7,12-trihydroxycholestan-26-oic acid)
Studies
(pipecolic acid)
Trials
(pipecolic acid)
Recent Studies (post-2010) (pipecolic acid)
31004924122

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiki, Y; Lazarow, PB; Moser, H; Small, GM; Watkins, P1

Other Studies

1 other study(ies) available for 3,7,12-trihydroxycholestan-26-oic acid and pipecolic acid

ArticleYear
Presence of the peroxisomal 22-kDa integral membrane protein in the liver of a person lacking recognizable peroxisomes (Zellweger syndrome).
    Proceedings of the National Academy of Sciences of the United States of America, 1986, Volume: 83, Issue:23

    Topics: Catalase; Cell Compartmentation; Cholestanols; Facial Bones; Fatty Acids; Female; Humans; Immunosorbent Techniques; Intracellular Membranes; Liver; Membrane Proteins; Microbodies; Molecular Weight; Muscle Hypotonia; Pipecolic Acids; Syndrome

1986